RIPK1 and neurodegenerative disease: Coupling these published RIPK1 findings with those of our studies demonstrating that RIPK3 deletion does not significantly affect Aβ amyloidosis suggests that RIPK1 likely contributes to neurodegenerative disease through its regulation of noncanonical inflammatory cytokine production and not via induction of RIPK3-dependent events.